title: The Information Technology Aided Relapse Prevention Programme in Schizophrenia: an extension of a mirror-design follow-up.
abstract: OBJECTIVE
  Decreasing a number of hospital admissions is important for improving outcomes for people with schizophrenia. The Information Technology Aided Relapse Prevention Programme in Schizophrenia (ITAREPS) programme enables early pharmacological intervention in psychosis by identification of prodromal symptoms of relapse using home telemonitoring via a phone-to-PC SMS platform.
  
  
  METHODS
  This study was a 1-year extension of a previously published mirror-design follow-up evaluation of programme clinical effectiveness. In total, 73 patients with psychotic illness (45 patients from original sample and 28 newly added subjects) collaborating with 56 family members participated in the clinical evaluation.
  
  
  RESULTS
  There was a statistically significant 77% decrease in the number of hospitalisations during the mean 396.8 +/- 249.4 days of participation in ITAREPS, compared with the same time period before participation in ITAREPS (Wilcoxon-signed ranks test, p < 0.00001), as well as significantly reduced number of hospitalisation days when in the ITAREPS (2365 hospitalisation days before and 991 days after ITAREPS enrolment respectively, Wilcoxon-signed ranks test, p < 0.003).
  
  
  CONCLUSIONS
  The ITAREPS programme represents an effective tool in the long-term treatment of patients with psychotic disorders.
authors.affiliation: Prague Psychiatric Center, Prague, Czech Republic. spaniel@pcp.lf3.cuni.cz
authors.forename: F
authors.initials: F
authors.lastname: Spaniel
authors.forename: P
authors.initials: P
authors.lastname: Vohlídka
authors.forename: J
authors.initials: J
authors.lastname: Kozený
authors.forename: T
authors.initials: T
authors.lastname: Novák
authors.forename: J
authors.initials: J
authors.lastname: Hrdlicka
authors.forename: L
authors.initials: L
authors.lastname: Motlová
authors.forename: J
authors.initials: J
authors.lastname: Cermák
authors.forename: C
authors.initials: C
authors.lastname: Höschl
mesh_terms: D000328:Adult; D005260:Female; D005500:Follow-Up Studies; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D008490:Medical Informatics / Q000379:methods*; D012559:Schizophrenia / Q000517:prevention & control*; D055502:Secondary Prevention
references.citation: Schizophr Bull. 1998;24(1):75-85
references.pmid: 9502547
references.citation: Neuropsychopharmacology. 2007 Oct;32(10):2057-66
references.pmid: 17327887
references.citation: Schizophr Res. 2008 Jan;98(1-3):312-7
references.pmid: 17920245
references.citation: Arch Gen Psychiatry. 2000 Mar;57(3):277-83
references.pmid: 10711914
references.citation: J Clin Psychiatry. 1996;57 Suppl 9:5-9
references.pmid: 8823344
references.citation: Arch Gen Psychiatry. 2005 Sep;62(9):975-83
references.pmid: 16143729
references.citation: Psychol Med Monogr Suppl. 1989;15:1-46
references.pmid: 2798648
references.citation: Schizophr Bull. 2006 Oct;32(4):609-13
references.pmid: 16914639
references.citation: Am J Psychiatry. 2005 Oct;162(10):1785-804
references.pmid: 16199825